Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-12-18 Ali-Jackson Kamil Chief Legal Officer Exercise or conversion · Restricted Stock Units −1,075 3,225
2016-12-18 Walker Neal President and CEO Exercise or conversion +2,925 874,908
2016-12-18 Walker Neal President and CEO Shares withheld for taxes −889 $31.25 $28K 874,019
2016-12-18 Walker Neal President and CEO Exercise or conversion · Restricted Stock Units −2,925 8,775
2016-12-18 Shanler Stuart Chief Scientific Officer Exercise or conversion +1,450 262,319
2016-12-18 Shanler Stuart Chief Scientific Officer Shares withheld for taxes −441 $31.25 $14K 261,878
2016-12-18 Shanler Stuart Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,450 4,350
2016-12-15 Shanler Stuart Chief Scientific Officer Grant or award · Stock option (right to buy) +62,400 62,400
2016-12-15 Shanler Stuart Chief Scientific Officer Grant or award · Restricted stock units +10,400 10,400
2016-12-15 Powala Christopher Chief Operating Officer Grant or award · Stock option (right to buy) +62,400 62,400
2016-12-15 Powala Christopher Chief Operating Officer Grant or award · Restricted stock units +10,400 10,400
2016-12-15 Ruffo Frank Chief Financial Officer Grant or award · Stock option (right to buy) +62,400 62,400
2016-12-15 Ruffo Frank Chief Financial Officer Grant or award · Restricted stock units +10,400 10,400
2016-12-15 Walker Neal President and CEO Grant or award · Stock option (right to buy) +145,600 145,600
2016-12-15 Walker Neal President and CEO Grant or award · Restricted stock units +24,266 24,266
2016-12-15 Ali-Jackson Kamil Chief Legal Officer Grant or award · Stock option (right to buy) +83,200 83,200
2016-12-15 Ali-Jackson Kamil Chief Legal Officer Grant or award · Restricted stock units +13,866 13,866
2016-11-18 VIVO VENTURES VII, LLC 10% owner Sale −440,402 $22.72 $10.0M 3,213,532
2016-11-18 VIVO VENTURES VII, LLC 10% owner Sale −9,598 $22.72 $218K 70,037
2016-11-16 VIVO VENTURES VII, LLC 10% owner Sale −448,063 $23.25 $10.4M 3,653,934

Page 51 of 57 · 1,130 trades